2009
Asthana, Sanjay, et al. “Frontiers Proposal. National Institute on Aging "bench to Bedside: Estrogen As a Case Study".”. Age (Dordr), vol. 31, no. 3, Sept. 2009, pp. 199-10, https://doi.org/10.1007/s11357-009-9087-2.
McCaffrey, Gwen, et al. “Occludin Oligomeric Assemblies at Tight Junctions of the Blood-Brain Barrier Are Altered by Hypoxia and Reoxygenation Stress.”. J Neurochem, vol. 110, no. 1, July 2009, pp. 58-71, https://doi.org/10.1111/j.1471-4159.2009.06113.x.
Liu, Lifei, et al. “Progesterone Increases Rat Neural Progenitor Cell Cycle Gene Expression and Proliferation via Extracellularly Regulated Kinase and Progesterone Receptor Membrane Components 1 and 2.”. Endocrinology, vol. 150, no. 7, July 2009, pp. 3186-96, https://doi.org/10.1210/en.2008-1447.
Brinton, Roberta Diaz. “Estrogen-Induced Plasticity from Cells to Circuits: Predictions for Cognitive Function.”. Trends Pharmacol Sci, vol. 30, no. 4, Apr. 2009, pp. 212-22, https://doi.org/10.1016/j.tips.2008.12.006.
Dvorak, Katerina, et al. “Expression of Bile Acid Transporting Proteins in Barrett’s Esophagus and Esophageal Adenocarcinoma.”. Am J Gastroenterol, vol. 104, no. 2, Feb. 2009, pp. 302-9, https://doi.org/10.1038/ajg.2008.85.
Yao, Jia, et al. “Mitochondrial Bioenergetic Deficit Precedes Alzheimer’s Pathology in Female Mouse Model of Alzheimer’s Disease.”. Proc Natl Acad Sci U S A, vol. 106, no. 34, Jan. 2009, pp. 14670-5, https://doi.org/10.1073/pnas.0903563106.
Nair, Padma, et al. “Novel Bifunctional Peptides As Opioid Agonists and NK-1 Antagonists”. Adv Exp Med Biol, vol. 611, Jan. 2009, pp. 537-8.
2008
Foy, Michael R, et al. “Estrogen and Hippocampal Plasticity in Rodent Models.”. J Alzheimers Dis, vol. 15, no. 4, Dec. 2008, pp. 589-03.
Brinton, Roberta Diaz. “The Healthy Cell Bias of Estrogen Action: Mitochondrial Bioenergetics and Neurological Implications.”. Trends Neurosci, vol. 31, no. 10, Oct. 2008, pp. 529-37, https://doi.org/10.1016/j.tins.2008.07.003.
Largent-Milnes, Tally M, et al. “Oxycodone Plus Ultra-Low-Dose Naltrexone Attenuates Neuropathic Pain and Associated Mu-Opioid Receptor-Gs Coupling.”. J Pain, vol. 9, no. 8, Aug. 2008, pp. 700-13, https://doi.org/10.1016/j.jpain.2008.03.005.
Irwin, Ronald W, et al. “Progesterone and Estrogen Regulate Oxidative Metabolism in Brain Mitochondria.”. Endocrinology, vol. 149, no. 6, June 2008, pp. 3167-75, https://doi.org/10.1210/en.2007-1227.
Junk, Damian J, et al. “Different Mutant Wild-Type P53 Combinations Cause a Spectrum of Increased Invasive Potential in Nonmalignant Immortalized Human Mammary Epithelial Cells.”. Neoplasia, vol. 10, no. 5, May 2008, pp. 450-61.
Brinton, Roberta Diaz, et al. “Progesterone Receptors: Form and Function in Brain.”. Front Neuroendocrinol, vol. 29, no. 2, May 2008, pp. 313-39, https://doi.org/10.1016/j.yfrne.2008.02.001.
Wang, Jun Ming, et al. “Regenerative Potential of Allopregnanolone.”. Brain Res Rev, vol. 57, no. 2, Mar. 2008, pp. 398-09, https://doi.org/10.1016/j.brainresrev.2007.08.010.
Watts, George S, et al. “DNA Methylation Changes in Ovarian Cancer Are Cumulative With Disease Progression and Identify Tumor Stage.”. BMC Med Genomics, vol. 1, Jan. 2008, p. 47, https://doi.org/10.1186/1755-8794-1-47.
Wang, Jun Ming, et al. “Estradiol-17beta-Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor Beta-Phosphorylated Extracellularly Regulated Kinase Pathway.”. Endocrinology, vol. 149, no. 1, Jan. 2008, pp. 208-18, https://doi.org/10.1210/en.2007-1155.
Brinton, Roberta Diaz. “Estrogen Regulation of Glucose Metabolism and Mitochondrial Function: Therapeutic Implications for Prevention of Alzheimer’s Disease.”. Adv Drug Deliv Rev, vol. 60, no. 13-14, Jan. 2008, pp. 1504-11, https://doi.org/10.1016/j.addr.2008.06.003.
Tumati, Suneeta, et al. “Intrathecal Raf-1-Selective SiRNA Attenuates Sustained Morphine-Mediated Thermal Hyperalgesia.”. Eur J Pharmacol, vol. 601, no. 1-3, Jan. 2008, pp. 207-8, https://doi.org/10.1016/j.ejphar.2008.10.033.
Vanderah, Todd W, et al. “Novel D-Amino Acid Tetrapeptides Produce Potent Antinociception by Selectively Acting at Peripheral Kappa-Opioid Receptors.”. Eur J Pharmacol, vol. 583, no. 1, Jan. 2008, pp. 62-72, https://doi.org/10.1016/j.ejphar.2008.01.011.
Streicher, J M, and Wang, Y. “The Role of COX-2 in Heart Pathology.”. Cardiovasc Hematol Agents Med Chem, vol. 6, no. 1, Jan. 2008, pp. 69-79.
2007
Goulet, Anne-Christine, et al. “Profiling of Selenomethionine Responsive Genes in Colon Cancer by Microarray Analysis.”. Cancer Biol Ther, vol. 6, no. 4, Apr. 2007, pp. 494-03.
Watts, George S, et al. “Identification of Fn14 TWEAK Receptor As a Potential Therapeutic Target in Esophageal Adenocarcinoma.”. Int J Cancer, vol. 121, no. 10, Jan. 2007, pp. 2132-9, https://doi.org/10.1002/ijc.22898.
2006
Ignatenko, Natalia A, et al. “Pharmacogenomics of the Polyamine Analog 3,8,13,18-Tetraaza-10,11-[(E)-1,2-Cyclopropyl]eicosane Tetrahydrochloride, CGC-11093, in the Colon Adenocarcinoma Cell Line HCT1161.”. Technol Cancer Res Treat, vol. 5, no. 6, Dec. 2006, pp. 553-64, https://doi.org/10.1177/153303460600500602.
Li, H, et al. “AP-2alpha and AP-2gamma Are Transcriptional Targets of P53 in Human Breast Carcinoma Cells.”. Oncogene, vol. 25, no. 39, Jan. 2006, pp. 5405-15, https://doi.org/10.1038/sj.onc.1209534.
Novak, Petr, et al. “Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer.”. Cancer Res, vol. 66, no. 22, Jan. 2006, pp. 10664-70, https://doi.org/10.1158/0008-5472.CAN-06-2761.